• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,461.15 933.20
( 1.24%)
Global Indices
Nasdaq
51,233.54 363.79
(0.72%)
Dow Jones
7,453.14 37.84
(0.51%)
Hang Seng
69,318.21 3,298.17
(5.00%)
Nikkei 225
10,460.24 156.36
(1.52%)
Forex
USD-INR
95.49 0.16
(0.17%)
EUR-INR
110.25 0.17
(0.15%)
GBP-INR
127.74 0.15
(0.12%)
JPY-INR
0.60 0.00
(0.21%)

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
532331
INE031B01049
338.0498657
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
AJANTPHARM
41.3
39096.73
EPS(TTM)
Face Value()
Div & Yield %
75.78
2
0.9
 

RPG Life Sciences consolidated net profit declines 74.52% in the March 2026 quarter
Apr 30,2026
Net profit of RPG Life Sciences declined 74.52% to Rs 29.90 crore in the quarter ended March 2026 as against Rs 117.35 crore during the previous quarter ended March 2025. Sales rose 23.62% to Rs 176.89 crore in the quarter ended March 2026 as against Rs 143.09 crore during the previous quarter ended March 2025.

For the full year,net profit declined 37.15% to Rs 115.17 crore in the year ended March 2026 as against Rs 183.24 crore during the previous year ended March 2025. Sales rose 8.28% to Rs 707.52 crore in the year ended March 2026 as against Rs 653.43 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales176.89143.09 24 707.52653.43 8
OPM %18.5617.81 -20.7924.43 -
PBDT44.8430.37 48 171.78171.71 0
PBT39.1025.00 56 150.30150.28 0
NP29.90117.35 -75 115.17183.24 -37